1E1Y
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | EMBL/DESY, HAMBURG BEAMLINE X13 |
| Synchrotron site | EMBL/DESY, HAMBURG |
| Beamline | X13 |
| Temperature [K] | 100 |
| Collection date | 2000-03-15 |
| Spacegroup name | P 43 21 2 |
| Unit cell lengths | 126.759, 126.759, 116.018 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 29.900 - 2.230 |
| R-factor | 0.195 |
| Rwork | 0.195 |
| R-free | 0.25200 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 2gpa |
| RMSD bond length | 0.007 |
| RMSD bond angle | 23.800 * |
| Data reduction software | DENZO |
| Data scaling software | SCALEPACK |
| Phasing software | X-PLOR (3.8) |
| Refinement software | X-PLOR (3.8) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 29.900 | 2.270 |
| High resolution limit [Å] | 2.230 | 2.230 |
| Rmerge | 0.104 | 0.433 |
| Total number of observations | 321450 * | |
| Number of reflections | 40691 | |
| <I/σ(I)> | 11.1 | 2.4 |
| Completeness [%] | 87.3 | 84.6 |
| Redundancy | 3.7 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | co-crystallization * | 6.7 | AS DESCRIBED PREVIOUSLY BY OIKONOMAKOS ET AL. (1999) PROTEIN SCIENCE 8, 1930-1945., pH 6.70 |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | 1 | enzyme | 25 (mg/ml) | |
| 2 | 1 | 1 | flavopiridol | 1 (mM) | |
| 3 | 1 | 1 | dithiothreitol | 3 (mM) | |
| 4 | 1 | 1 | Bes | 10 (mM) | |
| 5 | 1 | 1 | EDTA | 0.1 (mM) | |
| 6 | 1 | 1 | sodium azide | 0.02 (%) | |
| 7 | 1 | 1 | spermine | 1 (mM) | or 10 mM magnesium acetate |
| 8 | 1 | 1 | glucose | 50 (mM) |
